Intranasal Oxytocin in Hypothalamic Obesity

< b > Conditions < /b > :   Craniopharyngioma;   Hypothalamic Obesity < br/ > < b > Interventions < /b > :   Drug: Syntocinon;   Drug: Placebo (for Syntocinon) < br/ > < b > Sponsor < /b > :   Shana McCormack, MD < br/ > < b > Not yet recruiting < /b > - verified July 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials